Carregant...
Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal
BACKGROUND: Lofexidine is a non-opioid treatment for opioid withdrawal syndrome. Its sympatholytic actions counteract the noradrenergic hyperactivity that occurs during abrupt opioid withdrawal. METHODS: The effect of lofexidine 2.16 and 2.88 mg/day on QTcF (QT interval, heart-rate corrected, Frider...
Guardat en:
| Publicat a: | Drug Alcohol Depend |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7153804/ https://ncbi.nlm.nih.gov/pubmed/31606589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2019.107596 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|